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Interleukin-6 (IL-6) is a pro-inflammatory cytokine and major mediator of the acute phase response. Single nucleotide polymorphisms
within the 5V flanking region ( 597G>A,  572G>C and  174G>C) have previously been associated with increased risk of coronary
heart disease and influencing transcription of IL-6 both in vitro and in vivo. In addition to these, a polymorphic AnTn tract is also present in
the promoter of IL-6. Analysis in five different primate species demonstrated a G allele at  597,  572 and  174 in all species. By
contrast, the AnTn tract was polymorphic in at least three species, and was roughly conserved in overall length despite an increase in the
relative proportion of A versus T in the evolution of the human sequence from that in the ancestor of the great apes. The effect of the AnTn
polymorphism on IL-6 levels was examined following coronary artery bypass graft surgery (CABG), a known inflammatory stimulus for IL-
6 production. One hundred and thirty-two patients undergoing CABG were genotyped for the AnTn tract by automated sequencing. Four
alleles were identified: A8T12 (allele frequency 0.35, 95% CI 0.29–0.40); A9T11 (0.26, 0.21–0.31); A10T11 (0.21, 0.16–0.26); and
A10T10 (0.18, 0.14–0.23). Isolation of the effect of different alleles of the AnTn tract on an identical haplotypic background for the other
polymorphisms in the promoter showed that individuals homozygous for A9T11 had significantly higher post-operative IL-6 levels than
A10T11 homozygotes (275F 46 pg/ml versus 152F 29; P= 0.04). The effect of the A8T12 allele could not be determined separately due to
strong allelic association with  174C. The conserved length of the AnTn tract and the association in vivo with IL-6 levels strongly suggest
the functionality of the tract on IL-6 expression, independent of contributions from other polymorphic sites within the promoter.
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1. Introduction variation affecting the expression of IL-6 could thereforeInflammatory processes are a key component of the
initiation and progression of atherosclerosis, with inflam-
matory cytokines being candidates as risk factors for coro-
nary heart disease (CHD). The pro-inflammatory cytokine,
interleukin-6 (IL-6) is a major mediator of the acute phase
response and elevated plasma IL-6 levels are associated with
increased risk and severity of CHD [1,2]. Polymorphic0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: rmhaseh@ucl.ac.uk (S.E. Humphries).have a causal role in influencing individual susceptibility to
disease. A number of common polymorphisms have previ-
ously been identified in the 5Vflanking region of the IL-6
gene including  597G>A,  572G>C,  174G>C [3–5],
and a polymorphic tract of A and T residues (AnTn) at
position  373 [3,4]. The  597A and  174C alleles
show almost complete allelic association in Caucasian
subjects [4,5], while the  572C allele almost always
occurs with the  174G allele [5]. These polymorphisms
are located adjacent to cis-acting regulatory elements in-
volved in controlling IL-6 expression at the level of tran-
scription, suggesting that they may influence the interaction
of proteins with the DNA at these sites [6] (see Fig. 1).
Fig. 1. Diagrammatic representation of the IL-6 gene intron–exon structure
(A) and 5V-flanking region (B). Positions of single nucleotide poly-
morphisms are indicated by arrows. Black boxes represent known and
putative regulatory elements. GRE, glucocorticoid response element; AP1,
activator protein 1; MRE, multiple response element; CRE, cAMP response
element; C/EBPh, CCAAT response element binding protein.
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allele and  174CC homozygotes had significantly higher
peak IL-6 levels following coronary artery bypass graft
surgery (CABG) [5], a defined physiological stimulus for
IL-6 production [7]. Furthermore, the  174C allele has
been associated with an increased risk of CHD in several
studies [8–11]. Experiments have revealed functional
effects of both these polymorphisms in vitro in reporter
gene assays following stimulation with IL-1 [3,4,12]. This
evidence supports the influence of genetic variation on IL-6
expression and susceptibility to CHD.
Initial studies suggested that the AnTn tract in the IL-6
promoter influences transcription in vitro in combination
with the other single nucleotide polymorphisms in natu-
rally occurring haplotypes [4]. We have investigated the
association between the AnTn tract genotype and baseline
and peak IL-6 levels in our previously published cohort
of elective CABG cases [5]. Additionally, we have
sequenced this region in a variety of primate species to
obtain insight into the ancestral sequence of the IL-6
promoter and to gain further clues as to the conservation
of this polymorphism and it’s potential functional signif-
icance on IL-6 regulation.2. Subjects and methods
2.1. Subjects
DNA samples from 132 elective CABG patients were
available, with information on baseline and post-operative
serum IL-6 levels at 6, 24, 48, 72 and 96 h after cardiopul-
monary bypass (CPB), together with genotype information
for IL-6  597G>A,  572G>C and  174G>C polymor-
phisms. Patient baseline characteristics, operative details
and genotype information for these polymorphisms are
described elsewhere [5,13]. All operations were performed
by one of only four consultant surgical staff, using a midline
sternotomy approach and standard operating procedures.
Hypothermic CPB was instituted by cannulation of the rightatrium and ascending aorta. Myocardial protection was
maintained by cross-clamp fibrillation.
2.2. Genotyping
Genotyping of the AnTn tract was performed by direct
automated sequencing (Applied Biosystems) of PCR prod-
ucts generated by primers flanking the polymorphic site.
Primer sequences were: forward 5V-CAGAAGAACTCA-
GATGACTGG-3V;reverse 5VCTGATTGGAAACCTTATT-
AAG-3V. PCR conditions were 95 jC for 5 min, followed by
35 cycles of 95 jC for 30 s, 55 jC for 30 s, and 72 jC for 45 s.
2.3. Sequencing of primate species
The IL-6 5V flanking sequence, from nucleotides
 633 to  79, was amplified by PCR from genomic
DNA of five non-human primate species (chimpanzee:
Pan troglodytes; bonobo: Pan paniscus; gorilla: Gorilla
gorilla; orangutan: Pongo pygmaeus; and baboon: Papio
papio) using the primers 5V-GGAGTCACACACTC-
CACCTG-3V and 5V-TCATGGGAAAATCCCACATT-3V.
The AnTn tract was amplified from an additional four
chimpanzees and one bonobo using the same primers as
those for genotyping human samples. PCR products were
sequenced directly as for genotyping.
2.4. Statistical analysis
Haplotypes were generated for all four IL-6 polymor-
phisms ( 597G>A,  572G>C, AnTn tract and  174G>
C) using the PHASE program. This adopts a statistical
method based on a Markov chain–Monte Carlo algorithm,
to reconstruct haplotypes by exploiting principles of popula-
tion genetics and coalescent theory that make predictions
about the patterns of haplotypes in natural populations [14].
IL-6 values were not normally distributed, therefore, data
were log-transformed prior to analysis and, for ease of
interpretation, the geometric means and approximate stan-
dard error of the mean are presented. To explore the possi-
bility of confounding variables on IL-6 levels by surgical
procedure, operative variables (including consultant
performing surgery, number of grafts, left internal mammary
artery graft, operation duration and CPB and aortic cross-
clamp times) were examined to see if they were predictive of
changes in IL-6 levels. Differences in these predictors were
examined via univariate ANOVA between haplotype groups.
Association between difference in IL-6 levels and haplotype
groups were assessed by two sample t-test and ANOVA. A v2
test was used to determine if genotype distribution was in
Hardy–Weinburg equilibrium.
2.5. Phylogenetic analysis
The molecular phylogeny of IL-6 flanking sequence and
evolutionary distances (excluding the AnTn tract) were
Table 1
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A10T10/A10T10 4 0.033. Results
3.1. Haplotype analysis of IL-6 promoter polymorphisms in
humans
Fig. 1B shows a schematic representation of the 5V-
flanking region of the human IL-6 gene, indicating the
proximity between polymorphic and cis-acting regulatory
sites. These include two potential glucocorticoid response
elements (GRE) at positions  557 and  466 (relative to
the major transcription start site), a recognition site for
activator protein-1 ( 283), and the multiple regulatory
domain ( 168 to  153) containing a cAMP response
element at position  163, a binding site for the transcrip-
tion factor C/EBPh ( 158) and an additional GRE.
Genotyping of the AnTn tract was performed by direct
automated sequencing of PCR products synthesised from
patients using primers flanking this region. Fig. 2 shows a
sample of electropherograms to illustrate genotyping of the
different alleles. The genotype of homozygous individuals
was achieved without difficulty (not shown), and in hetero-
zygous individuals the overlap of peaks could be used to
identify the different number of A and T nucleotides present
on each chromosome (Fig. 2A). The presence of a ‘frame-
shift’ identified by split peaks, following the AnTn tract,
indicates a length difference between the two alleles as
shown in Fig. 2B. In most cases, genotyping was deter-Fig. 2. Sequencing electropherograms illustrating genotyping of the AnTn tract. (A
junction of the AnTn tract can be used to identify the number of A and T nucle
A10T10: the lack of overlapping peaks as in (A) indicates both alleles have the
indicates a frameshift as a result of one allele being longer than the other by a single
of A nucleotides combined with a ‘frameshift’ indicating an overall size differenc
strand in this case, due to the possible combinations of the number of A and T resi
assign the number of A and T nucleotides in each allele given their overall lengtmined easily from the sequence of one strand only; how-
ever, for certain combinations of alleles, sequencing in both
forward and reverse directions was required to accurately
assign genotypes (Fig. 2C). Only four different alleles were
identified in this sample: A8T12 (allele frequency 0.35,
95% CI 0.29–0.40); A9T11 (0.26, 0.21–0.31); A10T11
(0.21, 0.16–0.26); and A10T10 (0.18, 0.14–0.23), with
genotype distribution in Hardy–Weinberg equilibrium. Ge-
notype frequencies are listed in Table 1.
Analysis of AnTn genotypes with the other IL-6 pro-
moter polymorphisms demonstrated that the  174C allele
occurs mainly (95%) with A8T12 (D = 0.92, P < 0.001),
with 5% of  174C occurring with the A9T11 allele. The
 572C allele was observed only with A10T10 (D = 0.53,
P < 0.001). Allele frequencies and allelic associations ob-
served were consistent with previous observations [4].
As individual polymorphisms are unlikely to act indepen-
dently to influence gene expression, haplotypes were gener-
ated for all four polymorphisms using a computer algorithm
(PHASE) based on principles of coalescent theory [14]. Eight) Genotype A8T12/A10T10: the two overlapping heterozygous peaks at the
otides given that both alleles are the same length. (B) Genotype A10T11/
same number of adenosines. Split peaks at the end of the poly d(T) tract
T nucleotide. (C) Genotype A9T11/A10T11: heterozygosity for the number
e of a single nucleotide precludes genotyping from the sequence of a single
dues. Sequencing of both forward and reverse strands is required in order to
h.
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frequency estimates for each haplotype are shown in Table 2.
AG[A8T12]C was the most common haplotype (frequency
0.33), with those haplotypes containing the (common) G
allele at all three SNP sites being seen with all four different
AnTn alleles, A9T11 and A10T11 being the two most
common (0.25 and 0.21, respectively). These data raise the
issue of which haplotype is the ancestral promoter haplotype
in humans and the extent of conservation of this region
throughout evolution.
3.2. Sequence analysis of the IL-6 promoter in primates
In an attempt to gain further insight into the potential
functionality and molecular ancestry of the AnTn tract, this
region of the IL-6 promoter was sequenced in a variety of
primate species (from  633 to  79). These included
DNA samples from five chimpanzees (four subspecies
verus, one subspecies schweinfurthii), two bonobos, one
gorilla, one orangutan and two baboons. Alignment of the
sequences shows a considerable degree of conservation
between human and primate species within this entire region
(not shown). Excluding the AnTn tract, the rate of substi-
tution (Fig. 3A) is approximately one-third the average rate
of substitution in non-coding intergenic DNA of great apes
[16], consistent with the action of strong purifying selection
maintaining cis-regulatory function. In addition, a likelihood
ratio test fails to reject evolutionary rate constancy (P>0.5),
which would be expected when the differences between
species are due to the fixation of neutral mutations by
genetic drift. The three SNPs present in humans were all
homozygous G in these primate samples, suggesting these
polymorphisms arose after the divergence of chimpanzee
and human and that the common G allele for all three
polymorphisms is ancestral. Two other base changes were
identified between all five primate species and the human
sequence. A substitution of C to T at position  454 and an
A to G change at position  239, with no evidence for these
sites being polymorphic. Neither of these base changes exist
within known cis-regulatory sites in the IL-6 promoter.
Analysis of the sequence demonstrates that the AnTn
tract is polymorphic in at least three different primate
species. The following alleles were identified: chimpanzee
A10T8, A9T9, A8T10; bonobo A8T10; gorilla A5T11,
A6T10; orangutan A2T15; and baboon A2T16, A2T13.
Alignment of the sequences around this region (Fig. 3B)
shows the evolution of the AnTn tract. In the lineage from
the common ancestor of the great apes to humans and
chimpanzees, the poly d(A) part of the tract appears to beTable 2
Frequency of IL-6 promoter haplotypes for the  597G>A,  572G>C, AnTn t
CABG surgery
Haplotype AG[A8T12]C GG[A9T11]G GG[A10T11]G GG[A10T10
n 78 59 51 27
Frequency 0.33 0.25 0.21 0.12expanding as the poly d(T) component contracts. The
overall length has remained fairly constant throughout,
expanding by approximately two nucleotides on the human
lineage after the split with the chimpanzee lineage. Both
within and among species the number of As and Ts are
inversely related (Fig. 3C). No common ancestral allele was
identified between the human samples in this cohort and any
of the primate species studied.
3.3. Effect of the IL-6 promoter AnTn tract polymorphism
on plasma IL-6 levels following CABG surgery
The change in IL-6 levels post-CABG was used to
examine the in vivo functionality of the AnTn tract. Com-
parison of specific haplotype combinations enables isolation
of the effects of individual polymorphisms on IL-6 levels on
a common genetic background. Baseline mean IL-6 levels
were independent of haplotype (data not shown) as expected
from previous data in this cohort [5]. Peak IL-6 levels, at 6
h following surgery, are presented in Table 3 (meanF S.E.)
for the different haplotype combinations. Haplotype groups
containing less than three subjects have been excluded
because the low number of individuals precludes any
meaningful statistical analysis. At time points beyond 6
h there was no significant effect of haplotype on IL-6 levels.
Firstly we first sought to confirm the effects of  572C
and  174CC on pre- and post-operative IL-6 levels previ-
ously observed [5]. Examination of only individuals with an
AG[A8T12]C haplotype in common, showed that individ-
uals with GC¯[A10T10]G had significantly higher IL-6
levels 6 h following surgery than GG¯[A10T10]G subjects
(Fig. 4A) (378F 255 versus 119F 28 pg/ml, respectively;
P= 0.05). In a similar analysis to isolate the effect of
 174G>C (Fig. 4B), compared to GG[A10T11]G¯ homo-
zygotes, AG[A8T12]C¯ homozygotes had significantly
higher peak IL-6 levels following surgery (152F 30 versus
283F 41 pg/ml, respectively; P= 0.02). Individuals hetero-
zygous for these two haplotypes demonstrated intermediate
IL-6 levels (179F 26 pg/ml) although this difference was
not statistically significant.
Comparison between groups with the identical haplo-
typic background of  597GG,  572GG and  174GG
allows investigation of the effects of individual alleles of the
AnTn tract on IL-6 levels independent of the three SNPs.
Fig. 4C shows that individuals homozygous for A9T11 had
81% higher IL-6 levels than A10T11 homozygotes
(275F 46 versus 152F 29 pg/ml, respectively; P= 0.04).
An intermediate effect was observed in heterozygous indi-
viduals carrying A9T11 and A10T11 who had 53% lowerract and  174G>C polymorphisms identified in 132 patients undergoing
]G GC[A10T10]G AG[A9T11]C AG[A8T12]G GG[A8T12]G
12 4 2 1
0.05 0.02 0.008 0.004
Fig. 3. (A) Phylogeny of primate IL-6 promoter (excluding the AnTn tract) shows branch lengths proportional to the estimated number of nucleotide
substitutions per site. The bonobo branch has length zero. (B) Alignment of the region surrounding the AnTn tract of the IL-6 promoter in various primate
species compared to the human sequence. The genotype of the AnTn tract for each sequence is indicated at the left. Dashes indicate gaps in the alignment. (C)
Graph showing that within and between species the number of A and T nucleotides are inversely related. Symbols represent alleles from human (triangle),
chimpanzee and bonobo (diamond), gorilla (circle), and orangutan and baboon (square).
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17% higher than A10T11 homozygotes, but this difference
did not reach statistical significance. In the presence of the
common GG[A10T11]G haplotype, a modest stepwise in-
crease was observed in mean IL-6 levels between individ-Table 3
Serum IL-6 concentration (pg/ml) 6 h following surgery for IL-6 promoter haplo
Haplotype 1 Haplotype 2
GG[A10T11]G AG[A8T12]C
GG[A10T11]G 152F 29 (n= 6) 179F 25 (n= 20)
AG[A8T12]C 283F 41 (n= 9)
GG[A9T11]G
Data are presented as meanF S.E.uals carrying the A9T11 and the A10T10 alleles (Fig. 4D),
although this difference was not significant (179F 36
versus 183F 28 pg/ml, respectively; P= 0.35). Of all vari-
ables measured on the operating procedure, only operation
duration and CPB time correlated with peak IL-6 levels.types
GC[A10T10]G GG[A9T11]G GG[A10T10]G
207F 32 (n= 5) 179F 36 (n= 9) 183F 28 (n= 4)
378F 255 (n= 4) 179F 17 (n= 23) 119F 28 (n= 12)
275F 46 (n= 8) 221F 58 (n= 7)
Fig. 4. Effect of IL-6 promoter haplotypes for  597G>A,  572G>C, AnTn and  174G>C polymorphisms on serum IL-6 levels 6 h following surgery.
Results presented as meanF S.E., significant differences in IL-6 levels between haplotypes are indicated. A value of P < 0.05 was taken as significant.
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between any of the haplotype groups and these variables,
therefore it is not possible for them to confound the
observed relationship between haplotype and peak IL-6
levels post-surgery.
As a result of strong allelic association, the A8T12 allele
could not be analysed in isolation from  174C in this
study. Of note, a single individual in the cohort was
homozygous for the haplotype GG[A10T10]G with serum
IL-6 of 324 pg/ml 6 h post-operatively, however, no
significant conclusions can be drawn from this observation
due to insufficient sample size.4. Discussion
In order to investigate whether the AnTn tract polymor-
phism in the promoter of the IL-6 gene has any association
with IL-6 levels in response to an inflammatory stimulus in
vivo, we genotyped a cohort of patients undergoing CABG
surgery to assess the effect of genotype on pre- and post-
operative serum IL-6 levels. Only four different alleles were
identified in this group, but subjects in this study were of
Caucasian origin from the UK and it is possible that
additional alleles may be identified in more diverse human
populations. After taking account of the effects on IL-6levels associated with the  174C and  572C haplotypes
previously reported [5], it appears that certain alleles of the
AnTn tract do influence IL-6 expression in response to a
defined physiological inflammatory stimulus (CABG), in-
dependent of the other polymorphisms in the promoter.
Compared to the GG[A10T11]G haplotype, the
GG[A9T11]G haplotype was associated with higher IL-6
levels, such that A9T11 homozygotes had 81% higher post-
operative IL-6 levels than A10T11 homozygotes, with
heterozygotes having approximately intermediate levels.
Published in vitro reporter assays showing that constructs
containing GG[A9T11]G had significantly higher promoter
activity than GG[A10T11]G in cells stimulated with IL-1
support this finding [4]. The GG[A10T10]G haplotype may
also be associated with higher levels than GG[A10T11]G
homozygotes, but the effect was smaller and the A10T10
allele is less frequent, so the differences were not statisti-
cally significant. These data suggest that either the presence
of A9T11 acts to increase transcription, or that A10T11 has
a repressive effect. Due to strong allelic association between
the  174C and the A8T12 allele, the effects of this allele
could not be analysed in isolation. Therefore, it remains
unclear whether the A8T12 allele has a significant influence
on IL-6 expression or whether the observed effect originated
exclusively from the  174C allele, shown to be functional
in vitro [3,4].
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tract of poly d(N) residues has been reported to affect the
regulation of transcription. These include a run of five or six
adenosines in the promoter of the matrix metalloproteinase 3
gene (MMP3; Stromelysin-1), and a polymorphic run of
guanosine residues in the promoter of the Kallikrein gene,
both of which have been shown to influence gene expres-
sion in an allele-specific manner [17,18]. A possible mech-
anism for differential effects on expression may be as a
result of an altered binding affinity for a transcriptional
activator, or repressor, between particular alleles, as is the
case for the MMP3 promoter polymorphism [17]. Alterna-
tively, distinct alleles may bind different transcription fac-
tors each with a particular effect on gene expression. This
switching of transcription factor specificity has been ob-
served for single nucleotide variation in the promoters of
numerous genes [19]. However, variation in the molecular
architecture of the DNA at this site may directly play a role
in influencing gene expression. Variation in the helical
structure resulting in bending of the DNA, or the formation
of secondary structure, dependant on the composition of the
AnTn tract, may result in steric hindrance of transcription
factors or other regulatory proteins to the DNA. In this way,
certain alleles of a VNTR-like repeat located in the promoter
region of the insulin gene (INS) form unusual DNA struc-
tures which affect transcription factor binding and influence
expression of INS [20].
Although it is clear that the ancestral allele of the three
SNPs in the promoter is G at all sites, no clear insights as to
the functionality of the AnTn tract can be gained from the
sequence comparison of this region in other primate species.
The failure to identify any ancestral AnTn allele across
species suggests that this site has been subject to continual
evolution. However, the strong linkage disequilibrium ob-
served between the A8T12 and  174C allele suggests that
the A8T12 allele is of recent origin. This inference is
supported by the geographically restricted range of
 174C, while common among Europeans, the allele is
exceedingly rare or absent among East Asians, native
Americans and African-Americans [21–24]. The observa-
tion that the length of the poly d(T) component of the tract
contracts as the poly d(A) expands through divergence
between the different primate species suggests a selection
pressure on the overall length of the tract. The inverse
relationship between the number of A and the number of
T nucleotides is not expected if the two components of the
tract are evolving independently. An unusual mutation
mechanism cannot be ruled out, but the apparent overall
length restriction of the AnTn tract suggests it may have
some functional role on influencing IL-6 expression, and
supports the hypothesis that this effect is mediated through
differences in the conformation of the DNA at this site, or
transcription factor binding affinity.
One limitation of this study is that the sample size is
small and we are thus unable to rule out small differences on
IL-6 levels associated with certain haplotypes. However, thesample is large enough to detect the raising effects on IL-6
levels associated with the AG[A8T12]C and GC[A10T10]G
haplotypes, and the lowering effects associated with the
GG[A10T11]G haplotype with reasonable statistical signif-
icance. Further studies in larger samples, particularly for the
GG[A9T11]G and GG[A10T11]G haplotypes are war-
ranted. It is possible that individual AnTn alleles make
differing contributions to IL-6 expression, acting to either
enhance or repress transcription. This may explain why only
significant effects were observed in this study in individuals
homozygous for the AnTn tract in which these effects would
be greatest. Further in vitro studies are currently underway
in order to test this hypothesis.
It is clear that regulation of IL-6 expression is complex
and subject to subtle variation by independent contributions
from combinations of factors at several polymorphic sites in
the promoter. Furthermore, differences in the effects of these
polymorphisms on IL-6 expression between different cell
types in vitro [3,4] suggests tissue specific regulation of the
gene adding further complexity. Investigation of the inter-
action between proteins and components of the transcription
machinery at these sites will lead to a better understanding
of transcriptional control and mechanisms by which these
polymorphisms influence susceptibility of disease.Acknowledgements
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